Skip to main content
Top
Published in: Journal of Clinical Immunology 2/2022

Open Access 01-02-2022 | Immunodeficiency | Original Article

T Cell Repertoire Abnormality in Immunodeficiency Patients with DNA Repair and Methylation Defects

Authors: Mingyan Fang, Zheng Su, Hassan Abolhassani, Wei Zhang, Chongyi Jiang, Bochen Cheng, Lihua Luo, Jinghua Wu, Shiyu Wang, Liya Lin, Xie Wang, Longlong Wang, Asghar Aghamohammadi, Tao Li, Xiuqing Zhang, Lennart Hammarström, Xiao Liu

Published in: Journal of Clinical Immunology | Issue 2/2022

Login to get access

Abstract

Both DNA damage response and methylation play a crucial role in antigen receptor recombination by creating a diverse repertoire in developing lymphocytes, but how their defects relate to T cell repertoire and phenotypic heterogeneity of immunodeficiency remains obscure. We studied the TCR repertoire in patients with the mutation in different genes (ATM, DNMT3B, ZBTB24, RAG1, DCLRE1C, and JAK3) and uncovered distinct characteristics of repertoire diversity. We propose that early aberrancies in thymus T cell development predispose to the heterogeneous phenotypes of the immunodeficiency spectrum. Shorter CDR3 lengths in ATM-deficient patients, resulting from a decreased number of nucleotide insertions during VDJ recombination in the pre-selected TCR repertoire, as well as the increment of CDR3 tyrosine residues, lead to the enrichment of pathology-associated TCRs, which may contribute to the phenotypes of ATM deficiency. Furthermore, patients with DNMT3B and ZBTB24 mutations who exhibit discrepant phenotypes present longer CDR3 lengths and reduced number of known pathology-associated TCRs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fischer A. Human primary immunodeficiency diseases: a perspective. Nat Immunol. 2004;5(1):23–30.PubMed Fischer A. Human primary immunodeficiency diseases: a perspective. Nat Immunol. 2004;5(1):23–30.PubMed
2.
go back to reference IJspeert H, et al. Strategies for B-cell receptor repertoire analysis in primary immunodeficiencies: from severe combined immunodeficiency to common variable immunodeficiency. Front Immunol. 2015;6:157.PubMedPubMedCentral IJspeert H, et al. Strategies for B-cell receptor repertoire analysis in primary immunodeficiencies: from severe combined immunodeficiency to common variable immunodeficiency. Front Immunol. 2015;6:157.PubMedPubMedCentral
3.
4.
go back to reference IJspeert H, et al. XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination. Blood. 2016;128(5):650–9.PubMedPubMedCentral IJspeert H, et al. XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination. Blood. 2016;128(5):650–9.PubMedPubMedCentral
5.
go back to reference Wong GK, et al. Immune dysregulation in immunodeficiency disorders: the role of T-cell receptor sequencing. J Autoimmun. 2017;80:1–9.PubMed Wong GK, et al. Immune dysregulation in immunodeficiency disorders: the role of T-cell receptor sequencing. J Autoimmun. 2017;80:1–9.PubMed
6.
go back to reference Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181–211.PubMedPubMedCentral Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181–211.PubMedPubMedCentral
7.
8.
go back to reference Pulivarthy SR, et al. Regulated large-scale nucleosome density patterns and precise nucleosome positioning correlate with V(D)J recombination. Proc Natl Acad Sci U S A. 2016;113(42):E6427–36.PubMedPubMedCentral Pulivarthy SR, et al. Regulated large-scale nucleosome density patterns and precise nucleosome positioning correlate with V(D)J recombination. Proc Natl Acad Sci U S A. 2016;113(42):E6427–36.PubMedPubMedCentral
9.
go back to reference Kondilis-Mangum HD, Wade PA. Epigenetics and the adaptive immune response. Mol Aspects Med. 2013;34(4):813–25.PubMed Kondilis-Mangum HD, Wade PA. Epigenetics and the adaptive immune response. Mol Aspects Med. 2013;34(4):813–25.PubMed
10.
go back to reference Auclair G, et al. Ontogeny of CpG island methylation and specificity of DNMT3 methyltransferases during embryonic development in the mouse. Genome Biol. 2014;15(12):545.PubMedPubMedCentral Auclair G, et al. Ontogeny of CpG island methylation and specificity of DNMT3 methyltransferases during embryonic development in the mouse. Genome Biol. 2014;15(12):545.PubMedPubMedCentral
11.
go back to reference Gatto S, et al. ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing. Nucleic Acids Res. 2017;45(10):5739–56.PubMedPubMedCentral Gatto S, et al. ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing. Nucleic Acids Res. 2017;45(10):5739–56.PubMedPubMedCentral
12.
go back to reference de Greef JC, et al. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am J Hum Genet. 2011;88(6):796–804.PubMedPubMedCentral de Greef JC, et al. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am J Hum Genet. 2011;88(6):796–804.PubMedPubMedCentral
13.
go back to reference O’Driscoll M, et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell. 2001;8(6):1175–85.PubMed O’Driscoll M, et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell. 2001;8(6):1175–85.PubMed
14.
go back to reference Buck D, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell. 2006;124(2):287–99.PubMed Buck D, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell. 2006;124(2):287–99.PubMed
15.
go back to reference Bakr A, et al. Involvement of ATM in homologous recombination after end resection and RAD51 nucleofilament formation. Nucleic Acids Res. 2015;43(6):3154–66.PubMedPubMedCentral Bakr A, et al. Involvement of ATM in homologous recombination after end resection and RAD51 nucleofilament formation. Nucleic Acids Res. 2015;43(6):3154–66.PubMedPubMedCentral
16.
go back to reference Muraki K, et al. The role of ATM in the deficiency in nonhomologous end-joining near telomeres in a human cancer cell line. PLoS Genet. 2013;9(3):e1003386.PubMedPubMedCentral Muraki K, et al. The role of ATM in the deficiency in nonhomologous end-joining near telomeres in a human cancer cell line. PLoS Genet. 2013;9(3):e1003386.PubMedPubMedCentral
17.
go back to reference Weitering TJ, et al. ATM: translating the DNA damage response to adaptive immunity. Trends Immunol. 2021;42(4):350–65.PubMed Weitering TJ, et al. ATM: translating the DNA damage response to adaptive immunity. Trends Immunol. 2021;42(4):350–65.PubMed
18.
go back to reference Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol. 2013;14(4):197–210.PubMed Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol. 2013;14(4):197–210.PubMed
19.
go back to reference Branzei D, Foiani M. Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol. 2008;9(4):297–308.PubMed Branzei D, Foiani M. Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol. 2008;9(4):297–308.PubMed
20.
go back to reference Tripathi V, et al. MRN complex-dependent recruitment of ubiquitylated BLM helicase to DSBs negatively regulates DNA repair pathways. Nat Commun. 2018;9(1):1016.PubMedPubMedCentral Tripathi V, et al. MRN complex-dependent recruitment of ubiquitylated BLM helicase to DSBs negatively regulates DNA repair pathways. Nat Commun. 2018;9(1):1016.PubMedPubMedCentral
21.
go back to reference Marechal A, Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol. 2013;5(9). Marechal A, Zou L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol. 2013;5(9).
22.
go back to reference Yu X, et al. Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development. J Allergy Clin Immunol. 2014;133(4):1109–15.PubMedPubMedCentral Yu X, et al. Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development. J Allergy Clin Immunol. 2014;133(4):1109–15.PubMedPubMedCentral
23.
go back to reference Lee YN, et al. Characterization of T and B cell repertoire diversity in patients with RAG deficiency. Sci Immunol. 2016;1(6). Lee YN, et al. Characterization of T and B cell repertoire diversity in patients with RAG deficiency. Sci Immunol. 2016;1(6).
24.
go back to reference Berland A, et al. PROMIDISalpha: a T-cell receptor alpha signature associated with immunodeficiencies caused by V(D)J recombination defects. J Allergy Clin Immunol. 2019;143(1):325-334 e2.PubMed Berland A, et al. PROMIDISalpha: a T-cell receptor alpha signature associated with immunodeficiencies caused by V(D)J recombination defects. J Allergy Clin Immunol. 2019;143(1):325-334 e2.PubMed
25.
go back to reference Driessen GJ, et al. Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity. J Allergy Clin Immunol. 2013;131(5):1367-75 e9.PubMed Driessen GJ, et al. Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity. J Allergy Clin Immunol. 2013;131(5):1367-75 e9.PubMed
26.
go back to reference Wu J, et al. T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;135(1):209–16.PubMed Wu J, et al. T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;135(1):209–16.PubMed
27.
go back to reference Wong GK, et al. Accelerated loss of TCR repertoire diversity in common variable immunodeficiency. J Immunol. 2016;197(5):1642–9.PubMedPubMedCentral Wong GK, et al. Accelerated loss of TCR repertoire diversity in common variable immunodeficiency. J Immunol. 2016;197(5):1642–9.PubMedPubMedCentral
28.
go back to reference Roskin KM, et al. IgH sequences in common variable immune deficiency reveal altered B cell development and selection. Sci Transl Med. 2015;7(302):302ra135.PubMedPubMedCentral Roskin KM, et al. IgH sequences in common variable immune deficiency reveal altered B cell development and selection. Sci Transl Med. 2015;7(302):302ra135.PubMedPubMedCentral
29.
go back to reference Seidel MG, et al. The European Society for Immunodeficiencies (ESID) Registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763–70.PubMed Seidel MG, et al. The European Society for Immunodeficiencies (ESID) Registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7(6):1763–70.PubMed
30.
go back to reference Thalhammer J, et al. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol. 2021. Thalhammer J, et al. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol. 2021.
31.
go back to reference Fang M, et al. Next generation sequencing data analysis in primary immunodeficiency disorders - future directions. J Clin Immunol. 2016;36(Suppl 1):68–75.PubMed Fang M, et al. Next generation sequencing data analysis in primary immunodeficiency disorders - future directions. J Clin Immunol. 2016;36(Suppl 1):68–75.PubMed
32.
go back to reference Liu X, et al. Systematic comparative evaluation of methods for investigating the TCRbeta repertoire. PLoS One. 2016;11(3):e0152464.PubMedPubMedCentral Liu X, et al. Systematic comparative evaluation of methods for investigating the TCRbeta repertoire. PLoS One. 2016;11(3):e0152464.PubMedPubMedCentral
33.
go back to reference Li Q, Wang K. InterVar: Clinical interpretation of genetic variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet. 2017;100(2):267–80.PubMedPubMedCentral Li Q, Wang K. InterVar: Clinical interpretation of genetic variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet. 2017;100(2):267–80.PubMedPubMedCentral
34.
go back to reference Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.PubMedPubMedCentral Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.PubMedPubMedCentral
35.
go back to reference Abolhassani H, et al. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. J Allergy Clin Immunol. 2018;141(4):1450–8.PubMed Abolhassani H, et al. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. J Allergy Clin Immunol. 2018;141(4):1450–8.PubMed
36.
go back to reference Abolhassani H, et al. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(6):1375–80.PubMedPubMedCentral Abolhassani H, et al. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(6):1375–80.PubMedPubMedCentral
37.
go back to reference Abolhassani H, et al. Common variable immunodeficiency or late-onset combined immunodeficiency: a new hypomorphic JAK3 patient and review of the literature. J Investig Allergol Clin Immunol. 2015;25(3):218–20.PubMed Abolhassani H, et al. Common variable immunodeficiency or late-onset combined immunodeficiency: a new hypomorphic JAK3 patient and review of the literature. J Investig Allergol Clin Immunol. 2015;25(3):218–20.PubMed
38.
go back to reference Bousfiha A, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40(1):66–81.PubMedPubMedCentral Bousfiha A, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40(1):66–81.PubMedPubMedCentral
39.
go back to reference Giovannetti A, et al. Skewed T-cell receptor repertoire, decreased thymic output, and predominance of terminally differentiated T cells in ataxia telangiectasia. Blood. 2002;100(12):4082–9.PubMed Giovannetti A, et al. Skewed T-cell receptor repertoire, decreased thymic output, and predominance of terminally differentiated T cells in ataxia telangiectasia. Blood. 2002;100(12):4082–9.PubMed
40.
go back to reference Britanova OV, et al. Dynamics of individual T cell repertoires: from cord blood to Centenarians. J Immunol. 2016;196(12):5005–13.PubMed Britanova OV, et al. Dynamics of individual T cell repertoires: from cord blood to Centenarians. J Immunol. 2016;196(12):5005–13.PubMed
41.
go back to reference Yager EJ, et al. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med. 2008;205(3):711–23.PubMedPubMedCentral Yager EJ, et al. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med. 2008;205(3):711–23.PubMedPubMedCentral
42.
go back to reference Nikolich-Zugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19(1):10–9.PubMed Nikolich-Zugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19(1):10–9.PubMed
43.
go back to reference Gomez-Tourino I, et al. T cell receptor beta-chains display abnormal shortening and repertoire sharing in type 1 diabetes. Nat Commun. 2017;8(1):1792.PubMedPubMedCentral Gomez-Tourino I, et al. T cell receptor beta-chains display abnormal shortening and repertoire sharing in type 1 diabetes. Nat Commun. 2017;8(1):1792.PubMedPubMedCentral
44.
go back to reference Elhanati Y, et al. Quantifying selection in immune receptor repertoires. Proc Natl Acad Sci U S A. 2014;111(27):9875–80.PubMedPubMedCentral Elhanati Y, et al. Quantifying selection in immune receptor repertoires. Proc Natl Acad Sci U S A. 2014;111(27):9875–80.PubMedPubMedCentral
45.
go back to reference Zvyagin IV, et al. Distinctive properties of identical twins’ TCR repertoires revealed by high-throughput sequencing. Proc Natl Acad Sci U S A. 2014;111(16):5980–5.PubMedPubMedCentral Zvyagin IV, et al. Distinctive properties of identical twins’ TCR repertoires revealed by high-throughput sequencing. Proc Natl Acad Sci U S A. 2014;111(16):5980–5.PubMedPubMedCentral
46.
go back to reference Kou ZC, et al. T-Cell receptor Vbeta repertoire CDR3 length diversity differs within CD45RA and CD45RO T-cell subsets in healthy and human immunodeficiency virus-infected children. Clin Diagn Lab Immunol. 2000;7(6):953–9.PubMedPubMedCentral Kou ZC, et al. T-Cell receptor Vbeta repertoire CDR3 length diversity differs within CD45RA and CD45RO T-cell subsets in healthy and human immunodeficiency virus-infected children. Clin Diagn Lab Immunol. 2000;7(6):953–9.PubMedPubMedCentral
47.
go back to reference Wang CY, et al. Analysis of the CDR3 length repertoire and the diversity of T cell receptor alpha and beta chains in swine CD4+ and CD8+ T lymphocytes. Mol Med Rep. 2017;16(1):75–86.PubMedPubMedCentral Wang CY, et al. Analysis of the CDR3 length repertoire and the diversity of T cell receptor alpha and beta chains in swine CD4+ and CD8+ T lymphocytes. Mol Med Rep. 2017;16(1):75–86.PubMedPubMedCentral
48.
go back to reference Motea EA, Berdis AJ. Terminal deoxynucleotidyl transferase: the story of a misguided DNA polymerase. Biochim Biophys Acta. 2010;1804(5):1151–66.PubMed Motea EA, Berdis AJ. Terminal deoxynucleotidyl transferase: the story of a misguided DNA polymerase. Biochim Biophys Acta. 2010;1804(5):1151–66.PubMed
49.
go back to reference Mickelsen S, et al. Modulation of terminal deoxynucleotidyltransferase activity by the DNA-dependent protein kinase. J Immunol. 1999;163(2):834–43.PubMed Mickelsen S, et al. Modulation of terminal deoxynucleotidyltransferase activity by the DNA-dependent protein kinase. J Immunol. 1999;163(2):834–43.PubMed
50.
go back to reference Li H, et al. Recombinatorial biases and convergent recombination determine interindividual TCRbeta sharing in murine thymocytes. J Immunol. 2012;189(5):2404–13.PubMed Li H, et al. Recombinatorial biases and convergent recombination determine interindividual TCRbeta sharing in murine thymocytes. J Immunol. 2012;189(5):2404–13.PubMed
51.
go back to reference Venturi V, et al. Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination. Proc Natl Acad Sci U S A. 2006;103(49):18691–6.PubMedPubMedCentral Venturi V, et al. Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination. Proc Natl Acad Sci U S A. 2006;103(49):18691–6.PubMedPubMedCentral
52.
go back to reference Stadinski BD, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17(8):946–55.PubMedPubMedCentral Stadinski BD, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17(8):946–55.PubMedPubMedCentral
53.
go back to reference Ghraichy M, et al. B-cell receptor repertoire sequencing in patients with primary immunodeficiency: a review. Immunology. 2017. Ghraichy M, et al. B-cell receptor repertoire sequencing in patients with primary immunodeficiency: a review. Immunology. 2017.
54.
go back to reference Lieber MR, et al. Lymphoid V(D)J recombination: nucleotide insertion at signal joints as well as coding joints. Proc Natl Acad Sci U S A. 1988;85(22):8588–92.PubMedPubMedCentral Lieber MR, et al. Lymphoid V(D)J recombination: nucleotide insertion at signal joints as well as coding joints. Proc Natl Acad Sci U S A. 1988;85(22):8588–92.PubMedPubMedCentral
55.
go back to reference Staples ER, et al. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol. 2008;153(2):214–20.PubMedPubMedCentral Staples ER, et al. Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene. Clin Exp Immunol. 2008;153(2):214–20.PubMedPubMedCentral
56.
go back to reference Nowak-Wegrzyn A, et al. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr. 2004;144(4):505–11.PubMed Nowak-Wegrzyn A, et al. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr. 2004;144(4):505–11.PubMed
57.
go back to reference Pashankar F, et al. Intact T cell responses in ataxia telangiectasia. Clin Immunol. 2006;120(2):156–62.PubMed Pashankar F, et al. Intact T cell responses in ataxia telangiectasia. Clin Immunol. 2006;120(2):156–62.PubMed
58.
go back to reference Hagleitner MM, et al. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet. 2008;45(2):93–9.PubMed Hagleitner MM, et al. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet. 2008;45(2):93–9.PubMed
60.
go back to reference Ammann AJ, Hong R. Autoimmune phenomena in ataxia telangiectasia. J Pediatr. 1971;78(5):821–6.PubMed Ammann AJ, Hong R. Autoimmune phenomena in ataxia telangiectasia. J Pediatr. 1971;78(5):821–6.PubMed
61.
go back to reference Choi M, Kipps T, Kurzrock R. ATM mutations in cancer: therapeutic implications. Mol Cancer Ther. 2016;15(8):1781–91.PubMed Choi M, Kipps T, Kurzrock R. ATM mutations in cancer: therapeutic implications. Mol Cancer Ther. 2016;15(8):1781–91.PubMed
62.
go back to reference Weemaes CM, et al. Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects. Eur J Hum Genet. 2013;21(11):1219–25.PubMedPubMedCentral Weemaes CM, et al. Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects. Eur J Hum Genet. 2013;21(11):1219–25.PubMedPubMedCentral
63.
go back to reference Law MH, Macgregor S, Hayward NK. Melanoma genetics: recent findings take us beyond well-traveled pathways. J Invest Dermatol. 2012;132(7):1763–74.PubMed Law MH, Macgregor S, Hayward NK. Melanoma genetics: recent findings take us beyond well-traveled pathways. J Invest Dermatol. 2012;132(7):1763–74.PubMed
64.
go back to reference Moschos SJ, et al. Suppressing the high-level expression and function of ATM in advanced-stage melanomas does not sensitize the cells to ionizing radiation. Cancer Biol Ther. 2009;8(19):1815–25.PubMed Moschos SJ, et al. Suppressing the high-level expression and function of ATM in advanced-stage melanomas does not sensitize the cells to ionizing radiation. Cancer Biol Ther. 2009;8(19):1815–25.PubMed
65.
go back to reference Yamamoto K, et al. Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice. J Cell Biol. 2012;198(3):305–13.PubMedPubMedCentral Yamamoto K, et al. Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice. J Cell Biol. 2012;198(3):305–13.PubMedPubMedCentral
66.
go back to reference Bredemeyer AL, et al. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature. 2006;442(7101):466–70.PubMed Bredemeyer AL, et al. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature. 2006;442(7101):466–70.PubMed
67.
go back to reference Hathcock KS, et al. ATM influences the efficiency of TCRbeta rearrangement, subsequent TCRbeta-dependent T cell development, and generation of the pre-selection TCRbeta CDR3 repertoire. PLoS One. 2013;8(4):e62188.PubMedPubMedCentral Hathcock KS, et al. ATM influences the efficiency of TCRbeta rearrangement, subsequent TCRbeta-dependent T cell development, and generation of the pre-selection TCRbeta CDR3 repertoire. PLoS One. 2013;8(4):e62188.PubMedPubMedCentral
68.
go back to reference Vacchio MS, et al. ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor alpha locus coding end breaks. Proc Natl Acad Sci U S A. 2007;104(15):6323–8.PubMedPubMedCentral Vacchio MS, et al. ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor alpha locus coding end breaks. Proc Natl Acad Sci U S A. 2007;104(15):6323–8.PubMedPubMedCentral
69.
go back to reference Feeney AJ. Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences. J Exp Med. 1990;172(5):1377–90.PubMed Feeney AJ. Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences. J Exp Med. 1990;172(5):1377–90.PubMed
70.
go back to reference Cherrier M, et al. Substantial N diversity is generated in T cell receptor alpha genes at birth despite low levels of terminal deoxynucleotidyl transferase expression in mouse thymus. Eur J Immunol. 2002;32(12):3651–6.PubMed Cherrier M, et al. Substantial N diversity is generated in T cell receptor alpha genes at birth despite low levels of terminal deoxynucleotidyl transferase expression in mouse thymus. Eur J Immunol. 2002;32(12):3651–6.PubMed
71.
go back to reference Schelonka RL, et al. Absence of N addition facilitates B cell development, but impairs immune responses. Immunogenetics. 2011;63(9):599–609.PubMedPubMedCentral Schelonka RL, et al. Absence of N addition facilitates B cell development, but impairs immune responses. Immunogenetics. 2011;63(9):599–609.PubMedPubMedCentral
72.
go back to reference Huang C, et al. The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A nephropathy. J Autoimmun. 2019;97:100–7.PubMed Huang C, et al. The landscape and diagnostic potential of T and B cell repertoire in Immunoglobulin A nephropathy. J Autoimmun. 2019;97:100–7.PubMed
73.
go back to reference Liu X, et al. T cell receptor beta repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis. 2019. Liu X, et al. T cell receptor beta repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis. 2019.
74.
go back to reference Choy KR, Watters DJ. Neurodegeneration in ataxia-telangiectasia: Multiple roles of ATM kinase in cellular homeostasis. Dev Dyn. 2018;247(1):33–46.PubMed Choy KR, Watters DJ. Neurodegeneration in ataxia-telangiectasia: Multiple roles of ATM kinase in cellular homeostasis. Dev Dyn. 2018;247(1):33–46.PubMed
75.
go back to reference Keane C, et al. The T-cell receptor repertoire influences the tumor microenvironment and is associated with survival in aggressive B-cell lymphoma. Clin Cancer Res. 2017;23(7):1820–8.PubMed Keane C, et al. The T-cell receptor repertoire influences the tumor microenvironment and is associated with survival in aggressive B-cell lymphoma. Clin Cancer Res. 2017;23(7):1820–8.PubMed
76.
go back to reference Kramer AC, et al. Dnmt3a regulates T-cell development and suppresses T-ALL transformation. Leukemia. 2017;31(11):2479–90.PubMedPubMedCentral Kramer AC, et al. Dnmt3a regulates T-cell development and suppresses T-ALL transformation. Leukemia. 2017;31(11):2479–90.PubMedPubMedCentral
77.
go back to reference Blanco-Betancourt CE, et al. Defective B-cell-negative selection and terminal differentiation in the ICF syndrome. Blood. 2004;103(7):2683–90.PubMed Blanco-Betancourt CE, et al. Defective B-cell-negative selection and terminal differentiation in the ICF syndrome. Blood. 2004;103(7):2683–90.PubMed
78.
go back to reference Ehrlich M, Jackson K, Weemaes C. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis. 2006;1:2.PubMedPubMedCentral Ehrlich M, Jackson K, Weemaes C. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis. 2006;1:2.PubMedPubMedCentral
79.
go back to reference Liang J, et al. Downregulation of ZBTB24 hampers the G0/1- to S-phase cell-cycle transition via upregulating the expression of IRF-4 in human B cells. Genes Immunol. 2016;17(5):276–82. Liang J, et al. Downregulation of ZBTB24 hampers the G0/1- to S-phase cell-cycle transition via upregulating the expression of IRF-4 in human B cells. Genes Immunol. 2016;17(5):276–82.
80.
go back to reference Hardikar S, et al. The ZBTB24-CDCA7 axis regulates HELLS enrichment at centromeric satellite repeats to facilitate DNA methylation. Protein Cell. 2020;11(3):214–8.PubMedPubMedCentral Hardikar S, et al. The ZBTB24-CDCA7 axis regulates HELLS enrichment at centromeric satellite repeats to facilitate DNA methylation. Protein Cell. 2020;11(3):214–8.PubMedPubMedCentral
81.
go back to reference Ghraichy M, et al. B-cell receptor repertoire sequencing in patients with primary immunodeficiency: a review. Immunology. 2018;153(2):145–60.PubMed Ghraichy M, et al. B-cell receptor repertoire sequencing in patients with primary immunodeficiency: a review. Immunology. 2018;153(2):145–60.PubMed
Metadata
Title
T Cell Repertoire Abnormality in Immunodeficiency Patients with DNA Repair and Methylation Defects
Authors
Mingyan Fang
Zheng Su
Hassan Abolhassani
Wei Zhang
Chongyi Jiang
Bochen Cheng
Lihua Luo
Jinghua Wu
Shiyu Wang
Liya Lin
Xie Wang
Longlong Wang
Asghar Aghamohammadi
Tao Li
Xiuqing Zhang
Lennart Hammarström
Xiao Liu
Publication date
01-02-2022
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 2/2022
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-021-01178-1

Other articles of this Issue 2/2022

Journal of Clinical Immunology 2/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine